The present landscape of clinical trials is significantly evolving, spurred by groundbreaking approaches to therapeutic development. From individualized medicine, leveraging genetic data to inform treatment plans, to the assessment of sophisticated immunotherapies, clinicians are witnessing a major shift in how we tackle disease. A key focus remain